Welcome to MS Views and News blog


MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

May 17, 2019

Accessing your medicines (MS and non-MS) can be confusing. BUT It doesn’t have to be.

  • For the Benefit of the Patient
    /
  • Healthcare Perspectives
    /
  • MS Drug Therapies
    /
PhRMA member companies are committed to helping patients make more informed health care decisions by providing more transparency about medicine…
For the Benefit of the Patient

May 14, 2019

PhRMA Launches New Website to Provide Patients with Medicine Cost Information

  • For the Benefit of the Patient
    /
  • MS Drug Therapies
    /
Washington, D.C. (May 8, 2019) — Pharmaceutical Research and Manufacturers of America (PhRMA) president and CEO Steven J. Ubl issued the…
For the Benefit of the Patient

May 9, 2019

Immune thrombocytopenia in alemtuzumab-treated MS patients: Incidence, detection, and management.

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
Cuker A1, Bass AD2, Nadj C3, Agius MA4, Steingo B5, Selmaj KW6, Thoits T7, Guerreiro A8, Van Wijmeersch B9, Ziemssen T10, Meuth SG11, LaGanke CC12, Thangavelu K13, Rodriguez CE13,14, Baker DP13, Margolin DH13,15, Jannsens A16. Author…
MS Drug Therapies

May 9, 2019

The role of iron and myelin in orientation dependent R2 * of white matter.

  • MS Research Study and Reports
    /
Abstract Brain myelin and iron content are important parameters in neurodegenerative diseases such as multiple sclerosis (MS). Both myelin and…
MS Research Study and Reports

May 8, 2019

GENENTECH TO PRESENT NEW OCREVUS (OCRELIZUMAB) DATA ANALYSES SHOWING SIGNIFICANT REDUCTION OF DISABILITY PROGRESSION IN RELAPSING AND PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS AT THE AAN ANNUAL MEETING

  • MS Research Study and Reports
    /
  • Ocrevus
    /
New analyses show the effect of OCREVUS on reducing the risk of disability progression is associated with exposure and lower…
MS Research Study and Reports

May 8, 2019

The Benefits of RECEPT Broad Spectrum Hemp Extract

  • Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)
    /
2018 was a breakthrough year for hemp extract and cannabidiols. From capsules, tinctures and pumps to patches, edibles, drinks, and…
Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)

May 8, 2019

Phase 3 Trial Finds Tysabri Lowers Serum Neurofilament Light Levels in SPMS Patients

  • MS Research Study and Reports
    /
  • Tysabri
    /
MAY 7, 2019 BY JOSE MARQUES LOPES, PHD Treatment with Tysabri (natalizumab) lowers the levels of the biomarker serum neurofilament light chain…
MS Research Study and Reports

May 8, 2019

Copaiba for Orthopedic Pain Relief

  • Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)
    /
If you are looking for a natural product to help you with pain, you may want to consider doTERRA Copaiba. Copaiba essential…
Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)

May 6, 2019

The Evolving Role of Patient Advocates

  • Additional MS resource sites
    /
While pharma has long had relationships with advocacy organizations, there is a growing wave of individual patients who are willing…
Additional MS resource sites

May 5, 2019

Multiple Sclerosis Symptoms Video: Swollen Legs and Feet. If you’re impacted by MS and suffer from swollen feet

  • Boster's MS Corner
    /
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: To receive The MS BEACON, e-Newsletter, Click here —————————————————— CLICK BOX to SUBSCRIBE to our MS Learning Channel on YouTube: …
Boster's MS Corner

Categories

Latest Blog Posts